Quick Answer
GYRE THERAPEUTICS, INC. reported Long Term Debt of $283.0 thousand for the year ending 2013.
- GYRE THERAPEUTICS, INC. showed a decrease of -75.1% in Long Term Debt from 2012 to 2013.
- This data is from GYRE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2015.
- XBRL data for this metric is available from 2010 to 2013 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $2.44 million | Q3 2011: $2.20 million | Q1 2012: $1.78 million | Q2 2012: $1.56 million | Q3 2012: $1.35 million | Q1 2013: $918.0 thousand | Q2 2013: $699.0 thousand | Q3 2013: $478.0 thousand | Q1 2014: $142.0 thousand.
- Over the full 4 years of available data (2010 to 2013), GYRE THERAPEUTICS, INC.'s Long Term Debt has declined by 79.0%.
- Historical annual values: Fiscal year 2013: $283.0 thousand | Fiscal year 2012: $1.14 million | Fiscal year 2011: $1.99 million | Fiscal year 2010: $1.35 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: